Subtotal $0.00
Shop Now
There is no FDA-approved tirzepatide pill. As of September 2026, tirzepatide, the drug in Mounjaro and Zepbound, is approved only as a once-weekly injection, and Eli Lilly has not announced an oral version. Lilly’s once-daily pill for weight management is Foundayo, which contains a different drug, orforglipron. Products sold online as “tirzepatide pills”, drops, sublingual tablets or patches are not FDA-approved. This guide explains why tirzepatide is an injection, how Foundayo differs, and what to know about products marketed as oral tirzepatide.
Peptide Labs does not sell tirzepatide, orforglipron or any prescription drug. This article is general information, not medical advice.
Key Takeaways
- No oral form of tirzepatide is FDA-approved, and Lilly's August 2026 pipeline update listed none.
- Foundayo (orforglipron) is Lilly's GLP-1 pill, but it is a different molecule from tirzepatide.
- Foundayo acts on the GLP-1 receptor only; tirzepatide acts on both GIP and GLP-1 receptors.
- "Tirzepatide" drops, lozenges and patches sold online have never been reviewed by the FDA.
Is there a tirzepatide pill?
No. The current Mounjaro and Zepbound labels, both revised in August 2026, list only injectable forms: single-dose pens, single-dose and multi-dose vials, and a multi-dose KwikPen. Lilly’s second-quarter 2026 results, published on August 5, 2026, described new work on orforglipron and on retatrutide, its investigational triple-hormone drug, but no oral tirzepatide program. For how the two tirzepatide brands differ, see Mounjaro vs Zepbound.
Why tirzepatide is an injection
Tirzepatide is a peptide built on the GIP hormone sequence, with a fatty acid chain attached and a molecular weight the label lists as about 4,813 daltons. Swallowed peptides are mostly broken down by stomach acid and digestive enzymes, and their size makes it hard for them to cross the gut wall. Injected under the skin, about 80% of a tirzepatide dose reaches the bloodstream, according to the label, and its half-life of about five days allows weekly dosing.
Making a peptide work as a pill is possible but difficult. Novo Nordisk did it with semaglutide by adding an absorption enhancer, and even then only about 1% to 2% of an oral dose is absorbed, the tablets have to be taken on an empty stomach, and each tablet contains far more drug than a weekly injection. Our Ozempic pill and Wegovy pill guides explain those products. Lilly took a different route for its pill.
Lilly's oral option: Foundayo (orforglipron)
The FDA approved Foundayo on April 1, 2026, for long-term weight management in adults with obesity, or with overweight and a weight-related condition. Orforglipron is a small molecule, not a peptide, so it is absorbed from an ordinary tablet, and its label has no food or water restrictions. In August 2026 Lilly said it had also submitted orforglipron to the FDA for type 2 diabetes.
| Tirzepatide (Mounjaro, Zepbound) | Orforglipron (Foundayo) | |
|---|---|---|
| Type of molecule | Peptide | Small molecule |
| Receptors activated | GIP and GLP-1 | GLP-1 only |
| Form | Weekly injection | Daily tablet |
| Food and water rules | None; any time of day | None on the label |
| Approved uses | Type 2 diabetes (Mounjaro); weight management and sleep apnea (Zepbound) | Weight management in adults |
| Average weight loss in main trial | About 15% to 21% over 72 weeks (SURMOUNT-1) | Up to 11.2% over 72 weeks (ATTAIN-1) |
| Boxed warning | Thyroid C-cell tumors | Thyroid C-cell tumors |
The weight-loss figures come from separate placebo-controlled trials with different designs, so they are not a head-to-head comparison. Orforglipron also brings interactions peptides usually do not: it is broken down by the liver enzyme CYP3A4, so some common medicines affect it. Our Foundayo guide covers its trials and safety, and semaglutide vs tirzepatide compares the two leading injections.
"Oral tirzepatide" products sold online
Search for a tirzepatide pill and you will find telehealth sites, med spas and online sellers offering “oral tirzepatide” as drops, sublingual tablets, lozenges, films, skin patches or nasal sprays. None of these is an FDA-approved medicine. In a January 2025 consumer alert, South Carolina’s attorney general warned that such formulations have never been evaluated by any regulatory agency and may never have been tested in people. There is no published clinical evidence that tirzepatide works when taken this way.
The FDA’s page on unapproved GLP-1 drugs used for weight loss, updated in 2026, adds broader warnings:
- Unapproved and compounded versions do not undergo FDA review for safety, effectiveness or quality.
- Products labeled “for research purposes” or “not for human consumption” but sold with dosing instructions are being marketed illegally.
- Counterfeit GLP-1 products may contain the wrong ingredient, too much, too little or none at all.
- Buy prescription medicines only from state-licensed pharmacies, and be wary of sellers who claim a compounded product is the same as an approved drug.
The FDA has received hundreds of adverse event reports linked to compounded tirzepatide and semaglutide, including hospitalizations from dosing errors. Our guide to peptides for weight loss explains the regulatory status of approved, compounded and research-only products, and our tirzepatide profile covers the molecule.
What about future tirzepatide pills?
Nothing announced suggests an oral tirzepatide is close. Lilly’s next obesity drug in its pipeline is retatrutide, another weekly injection, which the company plans to submit to the FDA in the first quarter of 2027. If an oral tirzepatide is ever developed, it would need its own clinical trials and FDA approval. Until then, anything sold as a tirzepatide pill is an unapproved product. For the tirzepatide injections’ safety information, see tirzepatide side effects.
Frequently Asked Questions
Is there a tirzepatide pill?
No. As of September 2026, tirzepatide is approved only as a weekly injection, sold as Mounjaro and Zepbound. Lilly has not announced an oral version.
Is Foundayo a tirzepatide pill?
No. Foundayo contains orforglipron, a different drug from Eli Lilly. It acts on the GLP-1 receptor only, while tirzepatide acts on both the GIP and GLP-1 receptors.
Do tirzepatide drops or sublingual tablets work?
They are not FDA-approved, and there is no published clinical evidence that tirzepatide works when taken by mouth, under the tongue or through the skin.
Is there an oral Mounjaro or Zepbound?
No. Both brands are injections only. Their labels list pens, vials and a KwikPen.
What GLP-1 pills are FDA-approved?
Oral semaglutide (Rybelsus and Ozempic tablets for type 2 diabetes, Wegovy tablets for weight management) and Foundayo (orforglipron) for weight management.
Is it safe to buy oral tirzepatide online?
The FDA warns that unapproved GLP-1 products have not been reviewed for safety, effectiveness or quality, and counterfeits exist. Peptide Labs does not sell tirzepatide in any form.
This article is general information, not medical advice. Peptide Labs does not sell prescription drugs, including any product named here. Read the Medication Guide that comes with a prescription, and ask a pharmacist or prescriber how this information applies to you.
Last reviewed September 2026.